Antibiotic Susceptibility of Neisseria gonorrhoeae Isolates from Guangzhou, China, during 2002–2011

Antibiotic susceptibility of Neisseria gonorrhoeae in Guangzhou during 2002–2011 showed that resistance to penicillin and ciprofloxacin was high, while ceftriaxone remained effective although there was a trend towards reduced sensitivity.

Saved in:
Bibliographic Details
Published inJapanese Journal of Infectious Diseases Vol. 67; no. 4; pp. 288 - 291
Main Authors Zheng, Heping, Yang, Bin, Wu, Xingzhong, Huang, Jinmei, Zeng, Weiying, Xue, Yaohua, Qin, Xiaolin, Lan, Yinyuan, Tang, Sanmei, Ou, Jiangli, Li, Yixin
Format Journal Article
LanguageEnglish
Published Japan National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee 2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Antibiotic susceptibility of Neisseria gonorrhoeae in Guangzhou during 2002–2011 showed that resistance to penicillin and ciprofloxacin was high, while ceftriaxone remained effective although there was a trend towards reduced sensitivity.
AbstractList Antibiotic susceptibility of Neisseria gonorrhoeae in Guangzhou during 2002–2011 showed that resistance to penicillin and ciprofloxacin was high, while ceftriaxone remained effective although there was a trend towards reduced sensitivity.
Antibiotic susceptibility of Neisseria gonorrhoeae in Guangzhou during 2002-2011 showed that resistance to penicillin and ciprofloxacin was high, while ceftriaxone remained effective although there was a trend towards reduced sensitivity.Antibiotic susceptibility of Neisseria gonorrhoeae in Guangzhou during 2002-2011 showed that resistance to penicillin and ciprofloxacin was high, while ceftriaxone remained effective although there was a trend towards reduced sensitivity.
Author Wu, Xingzhong
Lan, Yinyuan
Zeng, Weiying
Huang, Jinmei
Zheng, Heping
Yang, Bin
Xue, Yaohua
Tang, Sanmei
Li, Yixin
Qin, Xiaolin
Ou, Jiangli
Author_xml – sequence: 1
  fullname: Zheng, Heping
  organization: Guangdong Provincial Center for Skin Diseases and STD Control
– sequence: 2
  fullname: Yang, Bin
  organization: Guangdong Provincial Center for Skin Diseases and STD Control
– sequence: 3
  fullname: Wu, Xingzhong
  organization: Guangdong Provincial Center for Skin Diseases and STD Control
– sequence: 4
  fullname: Huang, Jinmei
  organization: Guangdong Provincial Center for Skin Diseases and STD Control
– sequence: 5
  fullname: Zeng, Weiying
  organization: Guangdong Provincial Center for Skin Diseases and STD Control
– sequence: 6
  fullname: Xue, Yaohua
  organization: Guangdong Provincial Center for Skin Diseases and STD Control
– sequence: 7
  fullname: Qin, Xiaolin
  organization: Guangdong Provincial Center for Skin Diseases and STD Control
– sequence: 8
  fullname: Lan, Yinyuan
  organization: Guangdong Provincial Center for Skin Diseases and STD Control
– sequence: 9
  fullname: Tang, Sanmei
  organization: Guangdong Provincial Center for Skin Diseases and STD Control
– sequence: 10
  fullname: Ou, Jiangli
  organization: Guangdong Provincial Center for Skin Diseases and STD Control
– sequence: 11
  fullname: Li, Yixin
  organization: Guangdong Provincial Center for Skin Diseases and STD Control
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25056075$$D View this record in MEDLINE/PubMed
BookMark eNp1kc9uEzEQxi1URP_AjTPykUM2eNfrtfeEqghKpYoeCmdr7IwTl40dbO8hnPoOfUOehC0JQULiNDOa3zej-eacnIQYkJDXNZtLpfi7XfyGYd7JeaPUM3JWK9VWjeLdyZTztq06ztpTcp7zPWONEDV7QU4bwUTHpDgjeBmKNz4Wb-ndmC1un8rBlx2Njn5GnzMmD3QVQ0xpHRGQXuc4QMFMXYobejVCWP1Yx3FGF2sfYEaXY_JhRZtp38-Hx4bV9Uvy3MGQ8dUhXpCvHz98WXyqbm6vrheXN5UVoi8Vtn2zNACNUc6xXnIhmTDYG2bAWbCdROR1uwTHLTrWStlLdNIYdMYagfyCvN3P3ab4fcRc9MZPNw0DBIxj1rVoVcen4-sJfXNAR7PBpd4mv4G003-smYDZHrAp5pzQHZGa6Sfn9W_ndSf15PyEN__g1hcoPoaSwA__E73fi-5zgRUeN0Ca_jHgX7g9KI4du4akMfBfMM-iAQ
CitedBy_id crossref_primary_10_1016_j_diagmicrobio_2018_06_004
crossref_primary_10_1128_AAC_01211_15
crossref_primary_10_1186_s12879_016_2172_0
crossref_primary_10_7883_yoken_JJID_2016_522
crossref_primary_10_1039_D1QM01277K
crossref_primary_10_1016_j_ijantimicag_2019_08_015
crossref_primary_10_1016_j_compositesb_2022_110384
crossref_primary_10_1371_journal_pone_0213312
crossref_primary_10_1186_s13018_021_02234_7
Cites_doi 10.1586/eri.09.63
10.2807/ese.15.47.19721-en
10.1097/OLQ.0b013e3180ca8f24
10.1186/1471-2334-13-35
10.3201/eid1701.100397
10.7326/0003-4819-148-8-200804150-00005
10.1136/sti.79.5.399
10.1517/14656560902731993
10.1586/14787210.4.4.619
10.3201/eid1308.060948
10.2807/ese.16.14.19833-en
10.1128/AAC.05760-11
10.1155/2011/960501
10.1097/01.olq.0000137905.94154.0a
10.1186/1471-2334-13-40
10.1093/jac/dks162
ContentType Journal Article
Copyright Authors
Copyright_xml – notice: Authors
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.7883/yoken.67.288
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1884-2836
EndPage 291
ExternalDocumentID 25056075
10_7883_yoken_67_288
article_yoken_67_4_67_288_article_char_en
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
.55
29J
2WC
3O-
53G
5GY
7.U
AAUGY
ACPRK
ADBBV
AENEX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BAWUL
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
JSF
JSH
KQ8
OK1
RJT
RNS
RZJ
TR2
W2D
X7M
XSB
ZXP
AAYXX
CITATION
OVT
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c559t-e492dbaa2b8ff09735705be9b0bafcac67ee314daf3cef047797ef7bbefbcb5e3
ISSN 1344-6304
1884-2836
IngestDate Fri Jul 11 03:27:19 EDT 2025
Mon Jul 21 05:49:31 EDT 2025
Tue Jul 01 05:08:17 EDT 2025
Thu Apr 24 23:09:54 EDT 2025
Thu Aug 17 20:30:47 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c559t-e492dbaa2b8ff09735705be9b0bafcac67ee314daf3cef047797ef7bbefbcb5e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/yoken/67/4/67_288/_article/-char/en
PMID 25056075
PQID 1548635051
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_1548635051
pubmed_primary_25056075
crossref_primary_10_7883_yoken_67_288
crossref_citationtrail_10_7883_yoken_67_288
jstage_primary_article_yoken_67_4_67_288_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-00-00
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – year: 2014
  text: 2014-00-00
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Japanese Journal of Infectious Diseases
PublicationTitleAlternate Jpn J Infect Dis
PublicationYear 2014
Publisher National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee
Publisher_xml – name: National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee
References 20. Zhong N, Zheng W, Wang F, et al. Analysis on the drug-resistance of Nersseria gonorrhoeae to Antibiotics in Hainan area from 2006-2011. Chin J Derm Venereol. 2013;27:56-7 (in Chinese).
27. Centers for Disease Control and Prevention. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates–United States, 2000–2010. MMWR Morb Mortal Wkly Rep. 2011;60:873-7.
24. Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother. 2009;10:555-77.
15. Chevalier B, Crenn Y, Cavallo JD, et al. Comparative activity of azithromycin against 100 strains of Neisseria gonorrhoeae. Pathol Biol (Paris). 1995;43:281-3.
17. Su X, Jiang F, Qimuge, et al. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006. Sex Transm Dis. 2007;34:995-9.
3. Tapsall J. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies. Expert Rev Anti Infect Ther. 2006;4:619-28.
5. Ison CA, Hussey J, Sankar KN, et al. Gonorrhoea treatment failures to cefixime and azithromycin in England. Euro Surveill. 2001;16:pii=19833.
28. Australian Gonococcal Surveillance Programme, Tapsall J. Annual report of the Australian Gonococcal Surveillance Programme, 2008. Commun Dis Intell Q Rep. 2009;33:268-74.
22. Olsen B, Pham TL, Golparian D, et al. Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011. BMC Infect Dis. 2013;doi:10.1186/1471-2334-13-40.
11. Wu XZ, Zheng HP, Li YW, et al. In vitro susceptibility to six antimicrobial agents and the resistance plasmids genotype of Neisseria gorrhoeae isolates from four cities in Guangdong. J Diagn Ther Dermato–Venereol. 2012;19:352-5 (in Chinese).
8. Unemo M, Golparian D, Nicholas R, et al. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012;56:1273-80.
1. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther. 2009;7:821-34.
6. Unemo M, Golparian D, Syversen G, et al. Two cases of verified clinical failures using internationally recommended first line cefixime for gonorrhoea treatment, Norway. Euro Surveill. 2010;15:pii=19721.
9. Ohnishi M, Saika T, Hoshina S, et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis. 2011;17:148-9.
12. NCSTD: Epidemiologic Reports of Syphilis and Gonorrheae Case Reports in China. [http://www.ncstdc.org/upfiles/201303/20130319152506703.pdf], accessed on 2012, 1 (in Chinese).
23. Sethi S, Golparian D, Bala M, et al. Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007–2011. BMC Infect Dis. 2013;doi:10.1186/1471-2334-13-35.
13. Lau JT, Kim JH, Lau M, et al. Prevalence and risk behaviors of Hong Kong males who seek cross-border same-sex partners in mainland China. Sex Transm Dis. 2004;31:568-74.
4. Yokoi S, Deguchi T, Ozawa T, et al. Treat to cefixime treatment for gonorrhea. Emerg Infect Dis. 2007;13:1275-7.
10. Zheng HP, Cao WL, Wu XZ, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in Guangzhou, China, 1996–2001. Sex Transm Infect. 2003;79:399-402.
29. Yan H, Yin YP, Dai XQ. Antimicrobial resistance in clinical isolates of Neisseria gonorrhoeae in China, 2008:an epidemiological study. Chin J Dermatol. 2011;44:472-5 (in Chinese).
19. Zhou X, Liu X, Zhang Z. Analysis of drug-resistance of Neisseria gonorrhoeae to antibiotics in Dalian from 2009-2011. China Health Care & Nutrition. 2013;1:388-9 (in Chinese).
7. Cámara J, Serra J, Ayats J, et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother. 2012;67:1858-60.
2. Workowski KA, Berman SM, Douglas JM Jr. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med. 2008;148:606-13.
25. Kirkcaldy RD, Ballard RC, Dowell D. Gonococcal resistance: are cephalosporins next? Curr Infect Dis Rep. 2011;13:196-204.
14. World Health Organization (WHO). Sensitivity testing of Neisseria gonorrhoeae: Methodologies for use by participants in the WHO Western Pacific regional surveillance programme. In: WHO/WPRO Regional Antimicrobial Surevillance Working Group Meeting Proceedings. 1992;33-4.
18. Gu WM, Yang Y, Wu l. Surveillance on antibiotic susceptibility of Neisseria gonorrhoeae from 1988 to 2002 in Shanghai. Chin J Dermatol. 2004;37:323-5 (in Chinese).
26. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Exp Rev Anti Infect Ther. 2009;7:821-34.
21. Jabeen K, Nizamuddin S, Irfan S, et al. Increasing trend of resistance to penicillin, tetracycline, and fluoroquinolone resistance in Neisseria gonorrhoeae from Pakistan (1992–2009). J Trop Med, 2011; 960501. doi: 10.1155/2011/960501.
16. Van Dyck E, Piot P, Meheus A. Bench-level laboratory manual for sexually transmitted diseases, VDT/89.443. Geneva: World Health Organization (WHO). 1989.
22
23
24
25
26
27
28
29
10
11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
References_xml – reference: 28. Australian Gonococcal Surveillance Programme, Tapsall J. Annual report of the Australian Gonococcal Surveillance Programme, 2008. Commun Dis Intell Q Rep. 2009;33:268-74.
– reference: 18. Gu WM, Yang Y, Wu l. Surveillance on antibiotic susceptibility of Neisseria gonorrhoeae from 1988 to 2002 in Shanghai. Chin J Dermatol. 2004;37:323-5 (in Chinese).
– reference: 10. Zheng HP, Cao WL, Wu XZ, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in Guangzhou, China, 1996–2001. Sex Transm Infect. 2003;79:399-402.
– reference: 19. Zhou X, Liu X, Zhang Z. Analysis of drug-resistance of Neisseria gonorrhoeae to antibiotics in Dalian from 2009-2011. China Health Care & Nutrition. 2013;1:388-9 (in Chinese).
– reference: 20. Zhong N, Zheng W, Wang F, et al. Analysis on the drug-resistance of Nersseria gonorrhoeae to Antibiotics in Hainan area from 2006-2011. Chin J Derm Venereol. 2013;27:56-7 (in Chinese).
– reference: 26. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Exp Rev Anti Infect Ther. 2009;7:821-34.
– reference: 6. Unemo M, Golparian D, Syversen G, et al. Two cases of verified clinical failures using internationally recommended first line cefixime for gonorrhoea treatment, Norway. Euro Surveill. 2010;15:pii=19721.
– reference: 17. Su X, Jiang F, Qimuge, et al. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006. Sex Transm Dis. 2007;34:995-9.
– reference: 22. Olsen B, Pham TL, Golparian D, et al. Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011. BMC Infect Dis. 2013;doi:10.1186/1471-2334-13-40.
– reference: 25. Kirkcaldy RD, Ballard RC, Dowell D. Gonococcal resistance: are cephalosporins next? Curr Infect Dis Rep. 2011;13:196-204.
– reference: 27. Centers for Disease Control and Prevention. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates–United States, 2000–2010. MMWR Morb Mortal Wkly Rep. 2011;60:873-7.
– reference: 21. Jabeen K, Nizamuddin S, Irfan S, et al. Increasing trend of resistance to penicillin, tetracycline, and fluoroquinolone resistance in Neisseria gonorrhoeae from Pakistan (1992–2009). J Trop Med, 2011; 960501. doi: 10.1155/2011/960501.
– reference: 13. Lau JT, Kim JH, Lau M, et al. Prevalence and risk behaviors of Hong Kong males who seek cross-border same-sex partners in mainland China. Sex Transm Dis. 2004;31:568-74.
– reference: 15. Chevalier B, Crenn Y, Cavallo JD, et al. Comparative activity of azithromycin against 100 strains of Neisseria gonorrhoeae. Pathol Biol (Paris). 1995;43:281-3.
– reference: 23. Sethi S, Golparian D, Bala M, et al. Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007–2011. BMC Infect Dis. 2013;doi:10.1186/1471-2334-13-35.
– reference: 14. World Health Organization (WHO). Sensitivity testing of Neisseria gonorrhoeae: Methodologies for use by participants in the WHO Western Pacific regional surveillance programme. In: WHO/WPRO Regional Antimicrobial Surevillance Working Group Meeting Proceedings. 1992;33-4.
– reference: 12. NCSTD: Epidemiologic Reports of Syphilis and Gonorrheae Case Reports in China. [http://www.ncstdc.org/upfiles/201303/20130319152506703.pdf], accessed on 2012, 1 (in Chinese).
– reference: 8. Unemo M, Golparian D, Nicholas R, et al. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012;56:1273-80.
– reference: 16. Van Dyck E, Piot P, Meheus A. Bench-level laboratory manual for sexually transmitted diseases, VDT/89.443. Geneva: World Health Organization (WHO). 1989.
– reference: 2. Workowski KA, Berman SM, Douglas JM Jr. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med. 2008;148:606-13.
– reference: 7. Cámara J, Serra J, Ayats J, et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother. 2012;67:1858-60.
– reference: 29. Yan H, Yin YP, Dai XQ. Antimicrobial resistance in clinical isolates of Neisseria gonorrhoeae in China, 2008:an epidemiological study. Chin J Dermatol. 2011;44:472-5 (in Chinese).
– reference: 3. Tapsall J. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies. Expert Rev Anti Infect Ther. 2006;4:619-28.
– reference: 9. Ohnishi M, Saika T, Hoshina S, et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis. 2011;17:148-9.
– reference: 1. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther. 2009;7:821-34.
– reference: 5. Ison CA, Hussey J, Sankar KN, et al. Gonorrhoea treatment failures to cefixime and azithromycin in England. Euro Surveill. 2001;16:pii=19833.
– reference: 24. Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother. 2009;10:555-77.
– reference: 11. Wu XZ, Zheng HP, Li YW, et al. In vitro susceptibility to six antimicrobial agents and the resistance plasmids genotype of Neisseria gorrhoeae isolates from four cities in Guangdong. J Diagn Ther Dermato–Venereol. 2012;19:352-5 (in Chinese).
– reference: 4. Yokoi S, Deguchi T, Ozawa T, et al. Treat to cefixime treatment for gonorrhea. Emerg Infect Dis. 2007;13:1275-7.
– ident: 26
  doi: 10.1586/eri.09.63
– ident: 18
– ident: 6
  doi: 10.2807/ese.15.47.19721-en
– ident: 12
– ident: 17
  doi: 10.1097/OLQ.0b013e3180ca8f24
– ident: 16
– ident: 23
  doi: 10.1186/1471-2334-13-35
– ident: 1
  doi: 10.1586/eri.09.63
– ident: 14
– ident: 28
– ident: 9
  doi: 10.3201/eid1701.100397
– ident: 2
  doi: 10.7326/0003-4819-148-8-200804150-00005
– ident: 20
– ident: 10
  doi: 10.1136/sti.79.5.399
– ident: 24
  doi: 10.1517/14656560902731993
– ident: 3
  doi: 10.1586/14787210.4.4.619
– ident: 4
  doi: 10.3201/eid1308.060948
– ident: 5
  doi: 10.2807/ese.16.14.19833-en
– ident: 8
  doi: 10.1128/AAC.05760-11
– ident: 21
  doi: 10.1155/2011/960501
– ident: 11
– ident: 13
  doi: 10.1097/01.olq.0000137905.94154.0a
– ident: 19
– ident: 15
– ident: 29
– ident: 22
  doi: 10.1186/1471-2334-13-40
– ident: 7
  doi: 10.1093/jac/dks162
– ident: 27
– ident: 25
SSID ssj0025510
Score 2.031723
Snippet Antibiotic susceptibility of Neisseria gonorrhoeae in Guangzhou during 2002–2011 showed that resistance to penicillin and ciprofloxacin was high, while...
Antibiotic susceptibility of Neisseria gonorrhoeae in Guangzhou during 2002-2011 showed that resistance to penicillin and ciprofloxacin was high, while...
SourceID proquest
pubmed
crossref
jstage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 288
SubjectTerms Anti-Bacterial Agents - pharmacology
antibiotic
Chi-Square Distribution
China - epidemiology
Cohort Studies
Drug Resistance, Bacterial
Gonorrhea - epidemiology
Gonorrhea - microbiology
Humans
Microbial Sensitivity Tests
Neisseria gonorrhoeae
Neisseria gonorrhoeae - drug effects
susceptibility
Title Antibiotic Susceptibility of Neisseria gonorrhoeae Isolates from Guangzhou, China, during 2002–2011
URI https://www.jstage.jst.go.jp/article/yoken/67/4/67_288/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/25056075
https://www.proquest.com/docview/1548635051
Volume 67
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Japanese Journal of Infectious Diseases, 2014, Vol.67(4), pp.288-291
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF61BVVcEG_CS4sEp9QhidevY0GFtFJzoRURF8u7nk0M1K5S-0BP_Af-Ib-EmV3bcVArhV6syJ7Y653PszOz82DsjVaJj1q8clxNrhvlhU4ISjpKj0Gm4GvPBGMeT_3JqTiaebOt7d1O1FJVyoG6vDKv5CZcxXPIV8qS_Q_OtjfFE_gb-YtH5DAeN-Lxfk4ZHwXVXP1cXZgAFRPranbNp2C22rOkPy_yYrlcFJBA_xBHROqlzStBgOTzy0VR2Z33zCaI1amLFFjRxEK4tIKvKbK4yFLzyn5Hoz2sA7uqCyrqSfs-rcL-dQFWqEzgvFksSdbU3ur3WYvRL2Yss8yMa0U5qWrSI4pfyLrOitHKTTltXJtrMRBXjMsGCG_0Cv2DNKNKKsbLcnaWlSVAR5S7Qji-a5sbD8CeC0PhoELld-W_bQdS41x0hbltOFjrBWPbVezfJScIQyp98bP4DvnADwbtn9aKeNcQiQ1Z7AexoAPSxs0VSrJDTG-zW2M0eKgXx6dZG6yEdp-tq9G8k03hoGe_6z55Tbm6_Q3tizlcbzoZFerkHrtbTzPft2O5z7Ygf8B2j-vojocMVnjm63jmheYtnnkHz7zBMyc88xbPe9ygeY9bLHPC8p9fvwnFj9jpx4OTDxOnbgPiKDR3SwdENE5lkoxlqDVVl_KCoSchkkOZoKhRfgDgjkSaaFeBHoogiALQgZSgpZIeuI_ZTl7k8JTxJBXCA9Ryk5ESI5FEvgxEGqmhDKlTpe6xfjN_sapr5FOrlh8x2so02ysG4mz32NuW-tzWhrmGLrSsaKk2hkOPvW6YF6Pcp808_DLwI4jJ1YDGAq6pPfbEcrW9vTFr0BZ4dvMHP2d36Pu1zsYXbKdcVvAS1e9SvjLI_AvoRemM
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antibiotic+Susceptibility+of+Neisseria+gonorrhoeae+Isolates+from+Guangzhou%2C+China%2C+during+2002%E2%80%932011&rft.jtitle=Japanese+Journal+of+Infectious+Diseases&rft.au=Zheng%2C+Heping&rft.au=Yang%2C+Bin&rft.au=Wu%2C+Xingzhong&rft.au=Huang%2C+Jinmei&rft.date=2014&rft.pub=National+Institute+of+Infectious+Diseases%2C+Japanese+Journal+of+Infectious+Diseases+Editorial+Committee&rft.issn=1344-6304&rft.eissn=1884-2836&rft.volume=67&rft.issue=4&rft.spage=288&rft.epage=291&rft_id=info:doi/10.7883%2Fyoken.67.288&rft.externalDocID=article_yoken_67_4_67_288_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1344-6304&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1344-6304&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1344-6304&client=summon